Coya Therapeutics, Inc.

General ticker "COYA" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $94.0M (TTM average)

Coya Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -13.5%.

Estimated limits based on current volatility of 4.6%: low 4.63$, high 5.08$

Factors to consider:

  • Total employees count: 6 as of 2022
  • Price in estimated range
  • Earnings for 3 months up through Q1 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [3.84$, 8.14$]
  • 2026-12-31 to 2027-12-31 estimated range: [3.96$, 8.34$]

Financial Metrics affecting the COYA estimates:

  • Positive: with PPE of -4.4 at the end of fiscal year the price was neutral
  • Negative: Operating cash flow per share per price, % of -11.66 <= 0.02
  • Negative: negative Operating income
  • Negative: negative Net income
  • Positive: Shareholder equity ratio, % of 86.14 > 64.15
  • Positive: -4.44 < Investing cash flow per share per price, % of -1.26
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Negative: Inventory ratio change, % of 6.17 > 0.80

Similar symbols

Short-term COYA quotes

Long-term COYA plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $6.00MM $3.55MM $7.95MM
Operating Expenses $13.91MM $20.80MM $30.50MM
Operating Income $-7.90MM $-17.25MM $-22.56MM
Non-Operating Income $0.64MM $1.65MM $1.33MM
R&D Expense $6.04MM $11.89MM $19.02MM
Income(Loss) $-7.26MM $-15.60MM $-21.22MM
Taxes $0.72MM $-0.72MM $0.00MM
Profit(Loss)* $-7.99MM $-14.88MM $-21.23MM
Stockholders Equity $35.64MM $39.58MM $43.03MM
Assets $41.26MM $44.35MM $49.95MM
Operating Cash Flow $-11.19MM $-10.29MM $-10.74MM
Investing Cash Flow $-0.54MM $-0.03MM $-1.16MM
Financing Cash Flow $38.43MM $16.03MM $20.39MM
Earnings Per Share** $-0.79 $-0.98 $-1.27

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.